Clinical Trial Update: A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase II clinical trial update evaluating dasatinib for relapsed or plateau-phase multiple myeloma, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Relapsed, Refractory or Plateau Phase Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29